242 related articles for article (PubMed ID: 9533155)
1. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.
Gelet A; Chapelon JY; Bouvier R; Souchon R; Pangaud C; Abdelrahim AF; Cathignol D; Dubernard JM
Eur Urol; 1996; 29(2):174-83. PubMed ID: 8647143
[TBL] [Abstract][Full Text] [Related]
3. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
[TBL] [Abstract][Full Text] [Related]
4. High-intensity focused ultrasound: complications and adverse events.
Thüroff S; Chaussy C
Mol Urol; 2000; 4(3):183-7;discussion 189. PubMed ID: 11062373
[TBL] [Abstract][Full Text] [Related]
5. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
7. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
[TBL] [Abstract][Full Text] [Related]
8. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
9. Results and side effects of high-intensity focused ultrasound in localized prostate cancer.
Chaussy C; Thüroff S
J Endourol; 2001 May; 15(4):437-40; discussion 447-8. PubMed ID: 11394458
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
11. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
12. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
13. Only carefully selected patients may have a beneficial effect of salvage cryoablation in recurrent prostate cancer after radiotherapy.
Elkjær MC; Borre M
Dan Med J; 2013 Dec; 60(12):A4756. PubMed ID: 24355453
[TBL] [Abstract][Full Text] [Related]
14. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.
Gelet A; Chapelon JY; Bouvier R; Rouvière O; Lasne Y; Lyonnet D; Dubernard JM
J Endourol; 2000 Aug; 14(6):519-28. PubMed ID: 10954310
[TBL] [Abstract][Full Text] [Related]
15. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
16. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
[TBL] [Abstract][Full Text] [Related]
17. Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer.
Saliken JC; Donnelly BJ; Brasher P; Ali-Ridha N; Ernst S; Robinson J
J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):199-208. PubMed ID: 10082109
[TBL] [Abstract][Full Text] [Related]
18. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
19. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
20. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer.
Rebillard X; Gelet A; Davin JL; Soulie M; Prapotnich D; Cathelineau X; Rozet F; Vallancien G
J Endourol; 2005; 19(6):693-701. PubMed ID: 16053358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
